Stocks and Investing
Stocks and Investing
Wed, November 17, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, November 16, 2021
Chris Cooley Initiated (ANIK) at Buy and Held Target at $55 on, Nov 16th, 2021
Chris Cooley of Stephens & Co., Initiated "Anika Therapeutics, Inc." (ANIK) at Buy and Held Target at $55 on, Nov 16th, 2021.
Chris has made no other calls on ANIK in the last 4 months.
There is 1 other peer that has a rating on ANIK. Out of the 1 peers that are also analyzing ANIK, all agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Young Li of "UBS" Initiated at Hold and Held Target at $46 on, Friday, July 16th, 2021
Contributing Sources